Exercise program aims to boost recovery after lung cancer surgery
NCT ID NCT07159646
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This pilot study will test whether a 6-month athletic program can improve lung function and quality of life in 10 patients who had surgery for non-small cell lung cancer. Participants will follow a supervised exercise plan and be compared to similar patients who did not exercise. The goal is to see if this approach helps recovery.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- athletic/physical protocol
- What this could lead to
- If it works, this could point toward a structured exercise program to help lung cancer patients recover better after surgery.
- What could go wrong
- This is a very small pilot study with only 10 participants, so results may not apply to everyone. It is too early to know if the program truly improves lung function or quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Pavia, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Direct-to-Tumor chemo blast halt advanced lung cancer?
- Smart patch and app aim to boost lung recovery after cancer surgery
- Targeted drug LDK378 takes aim at rare ROS1-driven lung cancer
- Custom-Made vaccine aims to stop lung cancer recurrence
- Radiation and immunotherapy combo before lung cancer surgery shows promise in early trial
- New study aims to tame cholesterol side effect of lung cancer drug